Document is current

Article History

Received: 2 November 2020

Accepted: 7 October 2021

First Online: 26 January 2022

Declarations

:

: All methods were approved by Institutional Review Board of Faculty of Medicine Udayana University/ Sanglah Public Hospital Denpasar. Four (4) sources of secondary data were used in the study. First source of data was an open access of the official government COVID-19 surveillance system. The data from the first source of data was presented in Fig. InternalRef removed of this manuscript. The second and third source of data were from program data maintained by local implementing units (IUs) of a comprehensive national HIV and AIDS program for FSW being managed by the United Nations Population Fund (UNFPA) with technical support from the Indonesian National Association of Sex Workers (OPSI) on behalf of the Ministry of Health. The data from the second and third source of data was presented in Figs. InternalRef removed, InternalRef removed and InternalRef removed as well as Tables InternalRef removed, InternalRef removed and InternalRef removed in this manuscript. Lastly, the fourth source of data was from records being maintained from a community-based screening/self-testing intervention that was being implemented by the researchers for this manuscript in 15 of the 23 cities and districts included in this study and it was presented in Table InternalRef removed of this manuscript. Informed consent was obtained from the all participants for the study especially for the fourth source of data. The protocol for this study may be found in reference [CitationRef removed]. On the other hand, informed consent was not required and was waived for the first three sources of data as confirmed by Institutional Review Board of Faculty of Medicine Udayana University/Sanglah Public Hospital, Denpasar, Bali. Institutional Review Board of Faculty of Medicine Udayana University/ Sanglah Public Hospital Denpasar decided to exempt three (the first to the third source of data) of the four sources of data used in the study from human subject’s ethical review as they consisted of aggregate data that contained no information of any kind on individuals. The fourth source of data from the community HIV screening trial underwent ethical review at the same IRB as mentioned before and was assigned approval number 612/UN 14.2.2.VII.14/LT/2020. All data collection method and analysis were carried out in accordance with the guideline of IRB as mentioned before.

: Not applicable.

: The authors declare no competing interests.